NEO - NeoGenomics, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• NeoGenomics Non-GAAP EPS of $0.03 beats by $0.06, revenue of $155.55M beats by $3.02M
• NeoGenomics Q4 2023 Earnings Preview
• NeoGenomics ruling seen having limited impact on estimates, Needham says
• Natera wins court order barring NeoGenomics from selling RaDaR assay (update)
• NeoGenomics Non-GAAP EPS of $0.00 beats by $0.08, revenue of $152M beats by $10M
• NeoGenomics Non-GAAP EPS of -$0.05 beats by $0.06, revenue of $146.92M beats by $9.49M
• NeoGenomics Q2 2023 Earnings Preview
• NeoGenomics cut to market perform at Raymond James on valuation run-up
• NeoGenomics up 21% as BTIG upgrades to Buy after strong Q1 beat
• NeoGenomics Non-GAAP EPS of -$0.09 beats by $0.06, revenue of $137.2M beats by $10.81M
• NeoGenomics Q1 2023 Earnings Preview
• NeoGenomics maintains fiscal 2023 guidance; says improving trends to continue
• Catalyst watch: Tesla deliveries, Walmart event and jobs report headline big week
• NeoGenomics launches RaDaR test to detect minimal residual disease
• NeoGenomics stock pops on launch of next-gen sequencing tests
• NeoGenomics upgraded to buy at Benchmark on performance improvement program
• NeoGenomics surges ~20% as Q4 revenue grows, net loss narrows; FY23 outlook above estimates
• NeoGenomics beats Q4 top and bottom line estimates; initiates FY23 outlook
• NeoGenomics Q4 2022 Earnings Preview
• NeoGenomics names Jeffrey Sherman as new CFO